Morgan Stanley Atri Cure, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Atri Cure, Inc. stock. As of the latest transaction made, Morgan Stanley holds 383,809 shares of ATRC stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

383,809

Previous 391,453 1.95%

Holding current value

$13.7 Million

Previous $8.91 Million 20.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.34 - $29.5 $155,478 - $225,498	-7,644 Reduced 1.95%	383,809 $10.8 Million
Q2 2024 Oct 17, 2024	SELL	$19.86 - $29.09 $11.5 Million - $16.8 Million	-578,440 Reduced 59.64%	391,453 $8.91 Million
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $11.5 Million - $16.8 Million	-578,440 Reduced 59.64%	391,453 $8.91 Million
Q1 2024 Oct 17, 2024	BUY	$28.21 - $37.78 $16.3 Million - $21.9 Million	578,440 Added 147.77%	969,893 $29.5 Million
Q1 2024 Aug 16, 2024	BUY	$28.21 - $37.78 $13.4 Million - $17.9 Million	475,115 Added 96.03%	969,893 $29.5 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $13.4 Million - $17.9 Million	475,115 Added 96.03%	969,893 $29.5 Million
Q4 2023 Aug 16, 2024	BUY	$32.99 - $43.25 $3.41 Million - $4.47 Million	103,325 Added 26.4%	494,778 $17.7 Million
Q4 2023 Feb 13, 2024	BUY	$32.99 - $43.25 $7.99 Million - $10.5 Million	242,079 Added 95.8%	494,778 $17.7 Million
Q3 2023 Nov 15, 2023	BUY	$41.12 - $57.73 $360,005 - $505,426	8,755 Added 3.59%	252,699 $11.1 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $1.5 Million - $1.84 Million	-37,144 Reduced 13.21%	243,944 $12 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $2.26 Million - $2.97 Million	63,000 Added 28.89%	281,088 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $2.4 Million - $3.4 Million	71,570 Added 48.85%	218,088 $9.68 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $655,872 - $902,275	17,147 Added 13.25%	146,518 $5.73 Million
Q2 2022 Oct 27, 2022	BUY	$35.1 - $66.01 $2.74 Million - $5.15 Million	78,054 Added 152.1%	129,371 $5.29 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $2.74 Million - $5.15 Million	78,054 Added 152.1%	129,371 $5.29 Million
Q1 2022 Oct 27, 2022	SELL	$57.43 - $71.39 $4.48 Million - $5.57 Million	-78,054 Reduced 60.33%	51,317 $3.37 Million
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $107,221 - $133,285	1,867 Added 3.78%	51,317 $3.37 Million
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $5,325 - $7,319	-84 Reduced 0.17%	49,450 $3.44 Million
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $3.43 Million - $4.18 Million	49,534 New	49,534 $3.45 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account